X
Xiao-Dong Zhu
Researcher at Fudan University
Publications - 166
Citations - 5158
Xiao-Dong Zhu is an academic researcher from Fudan University. The author has contributed to research in topics: Hepatocellular carcinoma & Medicine. The author has an hindex of 27, co-authored 129 publications receiving 3734 citations. Previous affiliations of Xiao-Dong Zhu include Fudan University Shanghai Medical College & Chinese Ministry of Education.
Papers
More filters
Journal ArticleDOI
Prognostic value of peritumoral heat-shock factor-1 in patients receiving resection of hepatocellular carcinoma
Zhang Jb,Kun Guo,Kun Guo,Hui-Chuan Sun,Hui-Chuan Sun,Xiao-Dong Zhu,Xiao-Dong Zhu,Bo-Heng Zhang,Bo-Heng Zhang,Zhifei Lin,Zhifei Lin,Bo Heng Zhang,Bo Heng Zhang,Yinkun Liu,Yinkun Liu,Zhenggang Ren,Zhenggang Ren,Jianping Fan,Jianping Fan +18 more
TL;DR: High peritumoral HSF1 expression can serve as a sensitive ‘readout’ for high-risk HCC ER, and could be a potential metabolic intervention target following curative resection.
Journal ArticleDOI
Neutropenia predicts better prognosis in patients with metastatic gastric cancer on a combined epirubicin, oxaliplatin and 5-fluorouracil regimen
Rujiao Liu,Mingzhu Huang,Xiaoying Zhao,Wei Peng,Si Sun,Jun Cao,Dongmei Ji,Chenchen Wang,Weijian Guo,Jin Li,Jiliang Yin,Xiao-Dong Zhu +11 more
TL;DR: Multivariate analyses of overall survival (OS) proved moderate and severe CIN were important prognostic factors whether regarding CIN as a time-varying covariate (TVC) or not and predicted longer OS and PFS in MGC patients treated with first-line EOF5 chemotherapy.
Journal ArticleDOI
Final Overall Survival Analysis of Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma: A Multicenter, Randomized Phase III Trial
Yuan Mei Zhang,Li Chen,Guoqing Hu,Ning Zhang,Xiao-Dong Zhu,Kunyu Yang,Feng Jin,Mei Si,Yu-Pei Chen,Wei Han Hu,Zhi-Bin Cheng,Si-Yang Wang,Ye Tian,Xicheng Wang,Yan Sun,Jin-Gao Li,Wen-Fei Li,Yuhong Li,Yan Ping Mao,Guan-Qun Zhou,Rui Sun,Xu Liu,Rui Guo,Guo Xian Long,Shao-Qiang Liang,Lin Li,Jing Huang,Jin-Hua Long,Jian Zang,Qiao-Dan Liu,Li Zou,Qiong-Fei Su,Baoxin Zheng,Yun Xiao,Ying Guo,Fei Han,Hao Yuan Mo,Jia-Wei Lv,Xiao-Jing Du,Cheng Xu,N F Liu,Ying-Qin Li,Fang Yun Xie,Ying Sun,Jun Ma,Ling Long Tang +45 more
TL;DR: In conclusion, induction chemotherapy before concurrent chemoradiotherapy improved OS significantly in patients with locally advanced nasopharyngeal carcinoma, without increasing the risk of late toxicities.
Journal ArticleDOI
PSCA polymorphisms and gastric cancer susceptibility in an eastern Chinese population.
Li Xin Qiu,Lei Cheng,Jing He,Zhi Rui Zhou,Mengyun Wang,Fei Zhou,Wei Jian Guo,Jin Li,Meng Hong Sun,Xiao Yan Zhou,Ya Nong Wang,Yajun Yang,Jiucun Wang,Li Jin,Xiao-Dong Zhu,Qingyi Wei,Qingyi Wei +16 more
TL;DR: The results indicated that the PSCA rs2294008 T and rs2976392 A alleles were low-penetrate risk factors for GCa in this study population, however, large and well-designed studies are warranted to validate the findings.
Journal ArticleDOI
Reduced expression of CD109 in tumor-associated endothelial cells promotes tumor progression by paracrine interleukin-8 in hepatocellular carcinoma
Bo-Gen Ye,Hui-Chuan Sun,Hui-Chuan Sun,Xiao-Dong Zhu,Xiao-Dong Zhu,Zong-Tao Chai,Yuan-Yuan Zhang,Yuan-Yuan Zhang,Jian-Yang Ao,Hao Cai,Hao Cai,De-Ning Ma,De-Ning Ma,Cheng-Hao Wang,Cheng-Hao Wang,Cheng-Dong Qin,Cheng-Dong Qin,Dong-Mei Gao,Dong-Mei Gao,Zhao-You Tang,Zhao-You Tang +20 more
TL;DR: CD109 expression on tumor vessels is a potential prognostic marker for HCC, and its reduced expression on TEC promoted tumor progression by paracrine IL-8.